- Home
- QVCGA vs BCTX Comparison
QVCGA vs BCTX Comparison
Compare QVCGA & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- BCTX
- Stock Information
- Founded
- QVCGA 1991
- BCTX 2014
- Country
- QVCGA United States
- BCTX Canada
- Employees
- QVCGA N/A
- BCTX N/A
- Industry
- QVCGA
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGA
- BCTX Health Care
- Exchange
- QVCGA NYSE
- BCTX Nasdaq
- Market Cap
- QVCGA 26.1M
- BCTX 23.5M
- IPO Year
- QVCGA N/A
- BCTX N/A
- Fundamental
- Price
- QVCGA $3.07
- BCTX $2.91
- Analyst Decision
- QVCGA
- BCTX Strong Buy
- Analyst Count
- QVCGA 0
- BCTX 1
- Target Price
- QVCGA N/A
- BCTX $32.00
- AVG Volume (30 Days)
- QVCGA 194.0K
- BCTX 320.4K
- Earning Date
- QVCGA 08-07-2025
- BCTX 06-16-2025
- Dividend Yield
- QVCGA N/A
- BCTX N/A
- EPS Growth
- QVCGA N/A
- BCTX N/A
- EPS
- QVCGA N/A
- BCTX N/A
- Revenue
- QVCGA $9,800,000,000.00
- BCTX N/A
- Revenue This Year
- QVCGA $2.89
- BCTX N/A
- Revenue Next Year
- QVCGA $0.45
- BCTX N/A
- P/E Ratio
- QVCGA N/A
- BCTX N/A
- Revenue Growth
- QVCGA N/A
- BCTX N/A
- 52 Week Low
- QVCGA $2.27
- BCTX $2.78
- 52 Week High
- QVCGA $39.74
- BCTX $29.40
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- BCTX 40.26
- Support Level
- QVCGA N/A
- BCTX $2.85
- Resistance Level
- QVCGA N/A
- BCTX $3.11
- Average True Range (ATR)
- QVCGA 0.00
- BCTX 0.18
- MACD
- QVCGA 0.00
- BCTX -0.01
- Stochastic Oscillator
- QVCGA 0.00
- BCTX 18.84
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.